Home » Posts tagged with » crizanlizumab
Novartis bags Adakveo FDA approval to reduce VOCs in sickle cell disease
Adakveo FDA approval : Swiss drugmaker Novartis has bagged approval for Adakveo (crizanlizumab-tmca) from the US Food and Drug Administration (FDA) for its use in sickle cell disease. Formerly known as SEG101, Adakveo has been indicated to be used for bringing down the frequency of vaso-occlusive crises (VOCs), or pain crises, in patients, aged 16 […]
Business News Today
- Deutsche Börse to acquire majority stake in Quantitative Brokers
- MetLife to acquire vision-care benefits company Versant Health for $1.6bn
- Delivery Hero to acquire Latin American business of Glovo in €230m deal
- Arthur J. Gallagher acquires crop insurance provider Kirksey Agency
- Klarna pockets $650m funding for e-commerce payment solutions
- Amazon India opens two new fulfilment centres in Hyderabad
- Volansi bags $50m in Series B round for middle-mile drone delivery services
- British clothing retailer Next to form JV with Victoria’s Secret UK
- Cocomels launches new Sugar Free Coconut Milk Caramels
- Verizon to acquire US prepaid wireless provider Tracfone Wireless from America Movil
